Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management

NCT02608177 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
Type 2 Diabetes

Interventions

DRUG: Linagliptin
DRUG: Glipizide

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]
[object Object]